134 related articles for article (PubMed ID: 8443743)
1. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction.
Largey JS; Meltzer SJ; Yin J; Norris K; Sauk JJ; Archibald DW
Cancer; 1993 Mar; 71(6):1933-7. PubMed ID: 8443743
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology.
Huang MF; Chang YC; Liao PS; Huang TH; Tsay CH; Chou MY
Oral Oncol; 1999 May; 35(3):296-301. PubMed ID: 10621851
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
4. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
Sakata K
J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas.
Largey JS; Meltzer SJ; Sauk JJ; Hebert CA; Archibald DW
Oral Surg Oral Med Oral Pathol; 1994 Mar; 77(3):260-3. PubMed ID: 8170656
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma.
Uzawa K; Yoshida H; Suzuki H; Tanzawa H; Shimazaki J; Seino S; Sato K
Int J Cancer; 1994 Sep; 58(6):814-7. PubMed ID: 7927873
[TBL] [Abstract][Full Text] [Related]
7. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers.
Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E
Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma.
el-Naggar AK; Lee MS; Wang G; Luna MA; Goepfert H; Batsakis JG
Cancer; 1993 Aug; 72(3):881-6. PubMed ID: 8101470
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
[TBL] [Abstract][Full Text] [Related]
10. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.
Sakai E; Tsuchida N
Oncogene; 1992 May; 7(5):927-33. PubMed ID: 1570156
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
[TBL] [Abstract][Full Text] [Related]
12. Detection of loss of heterozygosity in the p53 tumor suppressor gene using a PCR-based assay.
Ridanpää M; Anttila S; Husgafvel-Pursiainen K
Pathol Res Pract; 1995 Jun; 191(5):399-402. PubMed ID: 7479357
[TBL] [Abstract][Full Text] [Related]
13. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.
Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW
J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733
[TBL] [Abstract][Full Text] [Related]
14. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N
Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726
[TBL] [Abstract][Full Text] [Related]
15. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of loss of heterozygosity (LOH) at the p53 and Rb suppressor genes in urinary bladder carcinoma].
Tamada H; Suzuki Y; Tamura G
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):722-30. PubMed ID: 7912753
[TBL] [Abstract][Full Text] [Related]
17. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.
Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ
Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
[TBL] [Abstract][Full Text] [Related]
20. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
